Upload others
View 3
Download 0
Embed Size (px) 344 x 292 429 x 357 514 x 422 599 x 487
Citation preview
ŠTÁTNY ÚSTAV PRE KONTROLU LIEČIV VÝROČNÁ …...EDQM European Directorate for the Quality of Medicines & Healthcare EMA European Medicines Agency EU European Union HMPC Committee
Data analytics subgroup report · See websites for contact details Heads of Medicines Agencies An agency of the European Union European Medicines Agency Data Analytics . Subgroup
Fredrik Melander Danish Agency for Science, Innovation and Technology
· PDF fileWorkflow-orale Antikoagulation bei VORBEMERKUNGEN. Benutzte Abkürzungen: ACCR American College of Chest Physicians EMA: European Medicines Agency
Prialt : EPAR - Product Information - European Medicines Agency
ПРИЛОЖЕНИЕ I - European Medicines Agency...повърхност, приложена на ден 0 от първия цикъл на лечение, последвани от
con Medicamento - European Medicines Agency
Equilis Prequenza Te - European Medicines Agency
LIITE I VALMISTEYHTEENVETO - European Medicines Agency - · - Levodopa/karbidopa-valmisteet voivat aiheuttaa vääriä positiivisia tuloksia virtsan moniliuskakokeessa ketonurian
ANVISA publica guia para submissão dos …...Institute for State Control of Veterinary Biologicals and Medicines (ISCVBM) Hudcova 56A CZ - 621 00 Brno Denmark Danish Medicines Agency
European Medicines Agency · 01! &%'"(2&-2%&%%*"!3"(-,+$!!!!! !
ΠΑΡΑΡΤΗΜΑ I - European Medicines Agency...Ηλικιωμένοι Μια μειωμένη αρχική δόση (5 mg/ημερησίως), αν και δεν αποτελεί
autorisé plus - European Medicines Agency
registrován není - European Medicines Agency · antiepileptik, anestetik a sedativních antihistaminik může dojít ke zvýraznění centrálního sedativního účinku. Současné
Work Programme in Greek - European Medicines Agency · 2000 " , ' . % " ( " '" ' % ( # 2001-2002 2.3 " / " , " '# , ( , # # , [' # (adr) ' # " " ' (psur)]. % ( " 24 2001 22 2002 %
European Medicines Agency€¦ · 5 '@ k < ( ; 5 *i1%*:# f #
ПРИЛОЖЕНИЕ I - European Medicines Agency › en › documents › referral › augmentin-ar… · Великобритания. Augmentin 1,2 g . 1000/200 mg . Прах
DODATAK I - European Medicines Agency
PRILOG I. - European Medicines Agency - · 4 4.3 Kontraindikacije Dokazani sindrom imunodeficijencije. Bolesnici s povećanim rizikom od oportunističkih infekcija, uključujući
Lijek koji više nije odobren - European Medicines Agency
Helen Shaw presentation - European Medicines Agency · Helen Shaw presentation Author: European Medicines Agency Created Date: 20130307121146Z
ПРИЛОЖЕНИЕ I - European Medicines Agency - Зависимост Употребата на бензодиазепини и бензодиазепин-подобни средства
Cubicin : EPAR - Scientific Discussion - European Medicines Agency
ΠΑΡΑΡΤΗΜΑ I - European Medicines Agency · Εάν το συμβάν επανεμφανιστεί, η θεραπεία με το Zydelig πρέπει να αναστέλλεται
European Medicines Agency | - ANNEXE I RÉSUMÉ …...4 Classified as public by the European Medicines A gency Le tofacitinib 10 mg deux fois par jour pour le traitement d’entretien
Παράρτημα ΙΙΙ - European Medicines Agency...13 Παράρτημα ΙΙΙ ΠΕΡΙΛΗΨΗ ΧΑΡΑΚΤΗΡΙΣΤΙΚΩΝ ΠΡΟΪΟΝΤΟΣ, ΕΠΙΣΗΜΑΝΣΗ ΚΑΙ
Hemangiol, INN - propranolol - European Medicines Agency - · 4.1 Terapinės indikacijos HEMANGIOL skiriamas esant proliferacinei kūdikių hemangiomai, kuriai reikia sisteminio gydymo:
ΠΑΡΑΡΤΗΜΑ I - European Medicines Agency · Σε ασθενείς με ιστορικό ή κλινικά σημαντική παθολογία του κεντρικού νευρικού
LYFJASTOFNUN Icelandic Medicines Control Agency Klínískar lyfjarannsóknir Klínískar lyfjarannsóknir Kolbeinn Guðmundsson Klínískar lyfjarannsóknir
I PIELIKUMS - European Medicines Agency...Infliksimaba drošums un efektivitāte juvenila idiopātiskā artrīta, psoriātiskā artrīta un ankilozējošā spondilīta ārstēšanā,
![Work Programme in Greek - European Medicines Agency · 2000 " , ' . % " ( " '" ' % ( # 2001-2002 2.3 " / " , " '# , ( , # # , [' # (adr) ' # " " ' (psur)]. % ( " 24 2001 22 2002 %](https://img.pdfslide.tips/doc/110x75/60b6b944c67f3b5df75d2ae0/work-programme-in-greek-european-medicines-agency-2000-.jpg)
